Abstract

In the BACHD mouse model of Huntington’s disease (HD), deletion of the N17 domain of the Huntingtin gene (BACHDΔN17, Q97) has been reported to lead to nuclear accumulation of mHTT and exacerbation of motor deficits, neuroinflammation and striatal atrophy (Gu et al., 2015). Here we characterized the effect of N17 deletion on dorsolateral striatal medium spiny neurons (MSNs) in BACHDΔN17 (Q97) and BACWTΔN17 (Q31) mice by comparing them to MSNs in wildtype (WT) mice. Mice were characterized on a series of motor tasks and subsequently whole cell patch clamp recordings with simultaneous biocytin filling of MSNs in in vitro striatal slices from these mice were used to comprehensively assess their physiological and morphological features. Key findings include that: Q97 mice exhibit impaired gait and righting reflexes but normal tail suspension reflexes and normal coats while Q31 mice do not differ from WT; intrinsic membrane and action potential properties are altered -but differentially so- in MSNs from Q97 and from Q31 mice; excitatory and inhibitory synaptic currents exhibit higher amplitudes in Q31 but not Q97 MSNs, while excitatory synaptic currents occur at lower frequency in Q97 than in WT and Q31 MSNs; there is a reduced total dendritic length in Q31 -but not Q97- MSNs compared to WT, while spine density and number did not differ in MSNs in the three groups. The findings that Q31 MSNs differed from Q97 and WT neurons with regard to some physiological features and structurally suggest a novel role of the N17 domain in the function of WT Htt. The motor phenotype seen in Q97 mice was less robust than that reported in an earlier study (Gu et al., 2015), and the alterations to MSN physiological properties were largely consistent with changes reported previously in a number of other mouse models of HD. Together this study indicates that N17 plays a role in the modulation of the properties of MSNs in both mHtt and WT-Htt mice, but does not markedly exacerbate HD-like pathogenesis in the BACHD model.

Highlights

  • Huntington’s Disease (HD) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansion in exon 1 of the Huntingtin gene (Htt) [1]

  • Wild-type (WT), BACWTΔN17 (Q31), and BACHDΔN17 (Q97) mice were weighed at 9 months of age prior to sacrifice and preparation of striatal slices for whole-cell patch clamp experiments

  • The N-terminal 17 amino acid domain (N17) domain of the Huntingtin gene, which regulates nuclear export of mutant Huntingtin protein (mHtt) has been suggested to play a pivotal role in mutant Htt aggregation and dysfunction [37,38,39,40,41,42,43,44,45,46]

Read more

Summary

Introduction

Huntington’s Disease (HD) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansion in exon 1 of the Huntingtin gene (Htt) [1]. Characterization of medium spiny neurons in the BACHDΔN17 mouse model of Huntington’s Disease of the mutant Huntingtin protein (mHtt) results in the manifestation of psychiatric, behavioral, and motor symptoms including choreiform movements and bradykinesia [2,3,4]. Employed models such as BACHD, R6/2, YAC128, and Q175 have contributed to our understanding of the pathophysiological consequences of mHtt expression in the striatum and other brain areas [28,29,30,31,32,33,34]. In these models, increased intrinsic excitability (associated with increased input resistance and reduced rheobase), reduction in excitatory postsynaptic current (EPSC) frequency and reductions in MSN dendritic spine density have been reported [28,29,30,31,32,33,34]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call